Biomarkers

Plasma biomarkers may accurately identify patients with low risk for kidney function loss after acute kidney injury

Study suggests that modifications of DNA at specific genomic sites correlate with levels of fibrosis in NAFLD

Breath testing results reflect current metabolic activities, detecting changes that may occur before symptoms are evident

The findings pave the way for prospective clinical trials designed to test whether this biomarker can improve outcomes

New biomarkers found in the eyes could unlock the key to helping manage diabetic retinopathy

The finding will indicate how aggressively physicians should treat patients with the associated condition

The LYNX panel analyzes both standard and novel molecular markers in the most common lymphoid neoplasms

Neurodegeneration can be identified using a combination of biomarkers in cerebrospinal fluid of living patients

New protein markers may indicate which patients have stable forms of CLL and which have more aggressive types

Combining urinary biomarkers improves clinical utility and provides a more robust evaluation